Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01101867 · ClinicalTrials.gov registry record · Phase 4
Prandial Insulin Dosing in Hospitalized Patients
A Phase 4 study, sponsored by Kathleen Dungan.
- Completed
- Registry status
- Phase 4
- Development phase
- 126
- Enrollment target
NCT01101867: Completed Phase 4 study, sponsored by Kathleen Dungan.
NCT01101867 is a Phase 4 study that has completed, run by Kathleen Dungan. The registered enrollment target is 126 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (76% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01101867, a Phase 4 study, has completed, sponsored by Kathleen Dungan.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 126 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether mealtime insulin results in better control of blood sugar than a fixed meal dose in hospitalized patients.
Primary Outcome
Mean glucose was calculated per participant from the average of glucose values over the 7-point (pre- and post-breakfast, lunch, dinner, and bed) glucose profile at day 3
Interventions
- DRUG Aspart fixed dose
- DRUG Aspart flexible dose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2010-06 |
| Est. Completion | 2013-03 |
| Phase | Phase 4 |
What the finished NCT01101867 record still lists
NCT01101867 is an interventional study that assigns participants to a tested intervention. The registered 126 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (76% lower).
The record links to 0 conditions, and to 2 interventions - of which Aspart fixed dose is the first listed.
NCT01101867 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01101867 about?
NCT01101867 is a clinical study titled "Prandial Insulin Dosing in Hospitalized Patients". The purpose of this study is to determine whether mealtime insulin results in better control of blood sugar than a fixed meal dose in hospitalized patients.
What is the current status of trial NCT01101867?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 126 participants. The study started on 2010-06. Estimated completion is 2013-03.
What interventions are being tested in trial NCT01101867?
The interventions under investigation include: Aspart fixed dose (DRUG), Aspart flexible dose (DRUG).
Who is sponsoring clinical trial NCT01101867?
This trial is sponsored by Kathleen Dungan, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01101867's enrollment target sits among peer trials
126 646th of 2000 higher than 1,354 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01873131 · 126 participants · NA
A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in Newborn
- NCT02621645 · 126 participants · Phase 4
TRAP Intervention STudy: Early Versus Late Intervention for Twin Reversed Arterial Perfusion Sequence
- NCT03838107 · 126 participants
Markers of Trajectory in Pediatric CRPS
- NCT03906422 · 126 participants · NA
Comparison of Patient-reported Pain After Initial Archwire Placement
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia